1. ALA2416558 F Antifungal activity against Saccharomyces cerevisiae RIA 259 Saccharomyces cerevisiae 7 organism-based format Scientific Literature 2. ALA2416559 F Antifungal activity against Aspergillus niger INA 00760 Aspergillus niger 7 organism-based format Scientific Literature 3. ALA2416560 F Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 Pseudomonas aeruginosa 7 organism-based format Scientific Literature 4. ALA2416561 F Antibacterial activity against Escherichia coli ATCC 25922 Escherichia coli 7 organism-based format Scientific Literature 5. ALA2416562 F Antibacterial activity against methicillin-resistant Staphylococcus aureus INA 00761 Staphylococcus aureus 7 organism-based format Scientific Literature 6. ALA2416563 F Antibacterial activity against vancomycin-resistant Leuconostoc mesenteroides VKPM B-4177 Leuconostoc mesenteroides 7 assay format Scientific Literature 7. ALA2416564 F Antibacterial activity against methicillin-susceptible Staphylococcus aureus FDA 209P Staphylococcus aureus 7 organism-based format Scientific Literature 8. ALA2416565 F Antibacterial activity against Micrococcus luteus NCTC 8340 Micrococcus luteus 7 organism-based format Scientific Literature 9. ALA2416566 F Antibacterial activity against Bacillus mycoides 537 Bacillus mycoides 7 organism-based format Scientific Literature 10. ALA2416567 F Antibacterial activity against Bacillus pumilus NCTC 8241 Bacillus pumilus 7 organism-based format Scientific Literature 11. ALA2416568 F Antibacterial activity against Bacillus subtilis ATCC 6633 Bacillus subtilis 7 organism-based format Scientific Literature 12. ALA2416570 F Bacteriostatic activity against rifampicin, isoniazid, streptomycin, ethambutol and pyrazinamide-resistant Mycobacterium tuberculosis MS-115 assessed as growth inhibition Mycobacterium tuberculosis 9 organism-based format Scientific Literature 13. ALA2416818 F Bacteriostatic activity against rifampicin, isoniazid, streptomycin, ethambutol and pyrazinamide-resistant Mycobacterium tuberculosis MS-115 assessed as growth inhibition at 5 ug/mL relative to control Mycobacterium tuberculosis 2 organism-based format Scientific Literature 14. ALA2416819 F Bacteriostatic activity against rifampicin, isoniazid, streptomycin, ethambutol and pyrazinamide-resistant Mycobacterium tuberculosis MS-115 assessed as growth inhibition at 10 ug/mL relative to control Mycobacterium tuberculosis 3 organism-based format Scientific Literature 15. ALA2416820 F Bacteriostatic activity against rifampicin, isoniazid, streptomycin, ethambutol and pyrazinamide-resistant Mycobacterium tuberculosis MS-115 assessed as growth inhibition at 20 ug/mL relative to control Mycobacterium tuberculosis 5 organism-based format Scientific Literature 16. ALA2416822 F Bacteriostatic activity against rifampicin, isoniazid, streptomycin, ethambutol and pyrazinamide-resistant Mycobacterium tuberculosis MS-115 assessed as growth inhibition at 50 ug/mL relative to control Mycobacterium tuberculosis 6 organism-based format Scientific Literature 17. ALA2416824 F Bacteriostatic activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition Mycobacterium tuberculosis 22 organism-based format Scientific Literature 18. ALA2416827 F Bacteriostatic activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition at 5 ug/mL relative to control Mycobacterium tuberculosis 7 organism-based format Scientific Literature 19. ALA2416828 F Bacteriostatic activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition at 10 ug/mL relative to control Mycobacterium tuberculosis 12 organism-based format Scientific Literature 20. ALA2416833 A Cytotoxicity against human A549 cells after 72 hrs by MTT assay Homo sapiens 20 cell-based format Scientific Literature